BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25
62 results:

  • 1. Comprehensive Analysis of MICALL2 Reveals Its Potential Roles in EGFR Stabilization and ovarian cancer Cell Invasion.
    Xia T; Ye F; Zhao W; Min P; Qi C; Wang Q; Zhao M; Zhang Y; Du J
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203692
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The long non-coding RNA NEAT1 promotes the progression of human ovarian cancer through targeting miR-214-3p and regulating angiogenesis.
    Liu Y; Li Y; Wu Y; Zhao Y; Hu X; Sun C
    J Ovarian Res; 2023 Nov; 16(1):219. PubMed ID: 37986114
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Agent-based modeling predicts rac1 is critical for ovarian cancer metastasis.
    Rivera M; Toledo-Jacobo L; Romero E; Oprea TI; Moses ME; Hudson LG; Wandinger-Ness A; Grimes MM
    Mol Biol Cell; 2022 Dec; 33(14):ar138. PubMed ID: 36200848
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment.
    Sriramkumar S; Metcalfe TX; Lai T; Zong X; Fang F; O'Hagan HM; Nephew KP
    PLoS One; 2022; 17(8):e0271584. PubMed ID: 35921335
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of key genes and pathways related to cancer-associated fibroblasts in chemoresistance of ovarian cancer cells based on GEO and TCGA databases.
    Han L; Guo X; Du R; Guo K; Qi P; Bian H
    J Ovarian Res; 2022 Jun; 15(1):75. PubMed ID: 35739532
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Machine learning approach informs biology of cancer drug response.
    Zhu EY; Dupuy AJ
    BMC Bioinformatics; 2022 May; 23(1):184. PubMed ID: 35581546
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial.
    Al-Samkari H; Kolb-Sielecki J; Safina SZ; Xue X; Jamieson BD
    Lancet Haematol; 2022 Mar; 9(3):e179-e189. PubMed ID: 35240074
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ovarian cancer G protein-coupled receptor 1 inhibits A549 cells migration through casein kinase 2α intronless gene and neutral endopeptidase.
    Sharma AL; Meitei PM; Machathoibi TC; Singh NT; Singh TR; Singh LS
    BMC Cancer; 2022 Feb; 22(1):143. PubMed ID: 35123428
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Somatic Mutational Profile of High-Grade Serous ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences.
    Serio PAMP; de Lima Pereira GF; Katayama MLH; Roela RA; Maistro S; Folgueira MAAK
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944094
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Linoleic and oleic acids enhance cell migration by altering the dynamics of microtubules and the remodeling of the actin cytoskeleton at the leading edge.
    Masner M; Lujea N; Bisbal M; Acosta C; Kunda P
    Sci Rep; 2021 Jul; 11(1):14984. PubMed ID: 34294745
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. IL-37bΔ1-45 suppresses the migration and invasion of endometrial cancer cells by targeting the rac1/NF-κB/MMP2 signal pathway.
    Wang X; Wei Z; Tang Z; Xue C; Yu H; Zhang D; Li Y; Liu X; Shi Y; Zhang L; Chen G; Zhou H; Wang J; Wang X
    Lab Invest; 2021 Jun; 101(6):760-774. PubMed ID: 33753880
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. DOCK7 protects against replication stress by promoting RPA stability on chromatin.
    Gao M; Guo G; Huang J; Hou X; Ham H; Kim W; Zhao F; Tu X; Zhou Q; Zhang C; Zhu Q; Liu J; Yan Y; Xu Z; Yin P; Luo K; Weroha J; Deng M; Billadeau DD; Lou Z
    Nucleic Acids Res; 2021 Apr; 49(6):3322-3337. PubMed ID: 33704464
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ezrin Promotes the Proliferation, Migration, and Invasion of ovarian cancer Cells.
    Li MJ; Xiong D; Huang H; Wen ZY
    Biomed Environ Sci; 2021 Feb; 34(2):139-151. PubMed ID: 33685573
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo.
    Grimes MM; Kenney SR; Dominguez DR; Brayer KJ; Guo Y; Wandinger-Ness A; Hudson LG
    BMC Cancer; 2021 Jan; 21(1):40. PubMed ID: 33413202
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Macrophage-mediated vascular permeability via VLA4/VCAM1 pathway dictates ascites development in ovarian cancer.
    Zhang S; Xie B; Wang L; Yang H; Zhang H; Chen Y; Wang F; Liu C; He H
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33295887
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains ovarian cancer Stem Cells.
    Zong X; Wang W; Ozes A; Fang F; Sandusky GE; Nephew KP
    Cancer Res; 2020 Oct; 80(20):4371-4385. PubMed ID: 32816909
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cucurbitacin I induces apoptosis in ovarian cancer cells through oxidative stress and the p190B‑rac1 signaling axis.
    Li R; Xiao J; Tang S; Lin X; Xu H; Han B; Yang M; Liu F
    Mol Med Rep; 2020 Sep; 22(3):2545-2550. PubMed ID: 32705204
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. POTEE promotes colorectal carcinoma progression via activating the rac1/Cdc42 pathway.
    Xu Q; Chen J; Peng M; Duan S; Hu Y; Guo D; Geng J; Zhou J
    Exp Cell Res; 2020 May; 390(1):111933. PubMed ID: 32142855
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.
    McGuire S; Kara B; Hart PC; Montag A; Wroblewski K; Fazal S; Huang XY; Lengyel E; Kenny HA
    Gynecol Oncol; 2019 May; 153(2):405-415. PubMed ID: 30797592
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer.
    Chellini L; Caprara V; Spadaro F; Sestito R; Bagnato A; Rosanò L
    Matrix Biol; 2019 Aug; 81():17-33. PubMed ID: 30367951
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.